The (THBI), the statewide public policy voice of the healthcare and bioscience industry, celebrating 30 years of advocacy ...

More than 100 Butler County leaders, school officials, teachers and high school students saw the official opening ceremony ...

The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas, March 30, 2026 /PRNewswire/ -- The Texas Healthcare & Bioscience Institute (THBI), the statewide public ...

Kaleido Biosciences Inc. company and executive profile by Barron's. View the latest KLDO company infomation and executive ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the ...

Earlier this month, at the Texas Healthcare & Bioscience Institute Life Sciences Summit in Austin, the state’s rising stature ...

The Phase 2a study results revealed that VIS-101 produced rapid and durable treatment responses with both 3 mg and 6 mg dose cohorts in patients with wet age-related macular degeneration (wet AMD).

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

AUSTIN, Texas, March 30, 2026 /PRNewswire/ -- The Texas Healthcare & Bioscience Institute (THBI), the statewide public policy voice of the healthcare and bioscience industry, today released a ...